When authorized generics are introduced to the market without any generic competition, does this help reduce payer cost and improve pharmacy margins?

Yes: 11.2%

No: 0%

Generally yes, but depends on pricing of AG and whether it’s reimbursed as a brand or generic: 44.4%

Generally no, but payer rebates and pharmacy discounts may help: 44.4%